We get the complexity of Oncology trials.
Our oncology specific AI delivers the complex insights around lines of therapy, biomarkers and progression, and our clinical teams verify the results enabling you to outsource the pre-screening process to us. AI enabled, human verified – each time.
OncoLens results for Research & Clinical Trial Leaders
From every patient to a verified match
What comes back to you
For every trial, a running account of where candidates went.
Trial matching and research tools powered by oncology AI
Turnkey trial screening with a human in the loop
- Each individual trial is set up to your team’s satisfaction.
- Alerts are sent as patients are verified by a human in the loop.
Biomarker and variant detection
- We excel at finding those rarer indications hidden in a scanned report of 50+ pages.
Trial flags at tumor board
- When implemented with our Conference module, trial candidates can be seamlessly presented for multidisciplinary discussion.
Feasibility and cohort analysis
- Size patient populations before you open a study, down to the specific eligibility criteria including lines of therapy, progression or biomarker.
Curated trials for your patient base
- Automatically benefit from established industry sponsor partnerships via the OncoLens Research Network.
- OncoLens does the feasibility work and pre-screening, you do the negotiations.
Case studies
A New Era in Trial Matching: How a Wisconsin-Based IDN Uses Real-Time Oncology Data to Drive Enrollment
A prostate cancer trial with no enrollments for over a year enrolled its first patient within a week of a real-time patient identification report.
Read the full case study →
Oncology-Focused AI/LLM To Find the Right Patients for Your Clinical Trials
OncoLens applied AI, natural language processing, and LLMs to pre-screen oncology trial candidates from structured and unstructured records, reducing manual chart review, with better accrual in trials such as diffuse large B-cell lymphoma and lungMAP.
Read the full case study →Frequently asked questions
What is AI clinical trial matching for cancer centers?
AI clinical trial matching screens a cancer center’s patients against open trial eligibility criteria automatically. OncoLens uses oncology-specific AI to read lines of therapy, biomarkers, and progression from notes and scanned reports, and a clinical reviewer verifies every potential match before your team is alerted.
Can we outsource pre-screening to OncoLens?
Yes. OncoLens provides pre-screening as a service as well as a platform: each trial is configured with your team, and verified candidates are delivered as alerts so research staff can focus on consent and enrollment.
Can OncoLens find rare biomarker populations?
Yes. OncoLens is built to detect rare biomarkers and variants that are often buried in lengthy scanned molecular reports, which structured-data searches typically miss.
How does OncoLens help us decide which trials to open?
Feasibility and cohort analysis sizes your patient population against specific eligibility criteria before a study opens, so you can prioritize trials your patients can actually enroll in.
What is the OncoLens Research Network and how does it benefit our center?
The OncoLens Research Network connects participating cancer centers with industry sponsors. OncoLens handles feasibility and pre-screening, bringing curated trial opportunities matched to your patient base.
Explore other audiences
OncoLens supports every team across the cancer program.
Cancer Executives
Run your cancer program on real-time insight
AudiencePhysicians & Tumor Board Teams
Less time on prep. Confidence that no patient falls through the cracks.
AudienceNavigators & Care Teams
Clarity on every patient, ready for your care.
AudienceRegistry & Quality Teams
Abstract faster. Report sooner. Stay survey ready.
AudienceIT, Data & AI Leaders
Oncology AI that scales with your needs and fits your governance.
Stop searching. Start enrolling.
See how OncoLens screens your patients against your open trials.